Literature DB >> 19870202

STUDIES ON MENINGOCOCCUS INFECTION : V. THE PRESENCE OF MENINGOCOCCUS PRECIPITINOGENS IN THE CEREBROSPINAL FLUID.

G Rake1.   

Abstract

Precipitin tests, carried out on the cerebrospinal fluid from cases of meningococcal meningitis with monovalent sera, demonstrate the presence in that fluid of type-specific precipitinogens of the meningococcus. Negative results are secured when the spinal fluid is obtained after the commencement of intrathecal serum treatment and also occasionally when the numbers of infecting organisms are very small. The reaction offers an easy and rapid method of ascertaining to which type of meningococcus a particular case of meningitis is due, and facilitates the immediate use of monovalent therapeutic antimeningococcal serum. Typing by means of the precipitin reaction can be confirmed by agglutination of the strain of organism responsible for the infection, if such strain be isolated. Confirmation by means of agglutination has been possible in all the cases discussed in this report. Spinal fluids from other diseases of the meninges and central nervous system fail to give any precipitin reaction with the monovalent sera.

Entities:  

Year:  1933        PMID: 19870202      PMCID: PMC2132302          DOI: 10.1084/jem.58.3.375

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  STUDIES ON MENINGOCOCCUS INFECTION : III. THE ANTIGENIC COMPLEX OF THE MENINGOCOCCUS-A TYPE-SPECIFIC SUBSTANCE.

Authors:  G Rake; H W Scherp
Journal:  J Exp Med       Date:  1933-08-31       Impact factor: 14.307

2.  STUDIES ON MENINGOCOCCUS INFECTION : II. MONOVALENT DIAGNOSTIC SERA PREPARED FROM "FRESH" AND "STOCK" STRAINS.

Authors:  G Rake
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

  2 in total
  1 in total

1.  STUDIES ON MENINGOCOCCUS INFECTION : X. A FURTHER NOTE ON THE PRESENCE OF MENINGOCOCCUS PRECIPITINOGENS IN THE CEREBROSPINAL FLUID.

Authors:  H E Alexander; G Rake
Journal:  J Exp Med       Date:  1937-02-28       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.